Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 July 2025 to Question 65186 on Asthma: Medical Equipment, which pharmaceutical companies are registered as marketing authorisation holders for (a) dry powder inhalers containing (i) salbutamol and (ii) terbutaline and (b) pressurised metered dose inhalers containing salbutamol.

The following table shows the four market authorisation holders (MAH) for dry power inhalers (DPIs) containing salbutamol and terbutaline, along with the three MAHs for pressurised metered dose inhalers (pMDIs):